Artivion, Inc. reported $471M of revenue over the trailing twelve months, +16% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $471M (to Q2 2026). Net income: −$3.2M, trailing twelve months to Q2 2026. Free cash flow: −$9.2M, trailing twelve months to Q2 2026. Operating margin: 4.6%, trailing twelve months to Q2 2026.

AORTArtivion, Inc.

Healthcare

$21.25-48% 1Y

$21.25

$20.1052 weeks$47.63

AORT as reported

Artivion, Inc. reported $471M of revenue over the trailing twelve months, +16% on the year before. 11 reported series are charted on this page, each one as filed.

$471M

Revenue, trailing twelve months · to Q2 2026 · +16% against the twelve months before

Net income: −$3.2M
Net income · −82% year on year · trailing twelve months to Q2 2026
Free cash flow: −$9.2M
Free cash flow · −219% year on year · trailing twelve months to Q2 2026
Operating margin: 4.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AORT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$471M	+16%	Q2 2026
Net income	−$3.2M	−82%	Q2 2026
EPS	−$0.07	−83%	Q2 2026
Gross margin	64%	n/a	Q2 2026
Operating margin	4.6%	n/a	Q2 2026
Net margin	−0.42%	n/a	Q2 2026
ROE	0.50%	n/a	Q2 2026
ROA	0.27%	n/a	Q2 2026
ROIC	3.8%	n/a	Q2 2026
Free cash flow	−$9.2M	−219%	Q2 2026
P/E	96.7	n/a	Q4 2017 · 34 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.